Inventor · disambiguated record
Kenneth M. Boy
Also filed as: BOY KENNETH M
28 granted patents·6 pending applications·317 citations·filing 2003–2023
96Inventor score
Top patents by PatentIndex Score
34 records- 0196US9308236B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Apr 12, 2016·51 cites·5 claims
- 0295US9879046B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Jan 30, 2018·17 cites·12 claims
- 0395US7173004B2Macrocyclic isoquinoline peptide inhibitors of hepatitis C virusBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Feb 6, 2007·90 cites·44 claims
- 0494US8486952B2Compounds for the reduction of β-amyloid productionBOY KENNETH M·Filed 2010·Granted Jul 16, 2013·34 cites·15 claims
- 0593US9856292B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jan 2, 2018·12 cites·32 claims
- 0693US8637525B2Compounds for the reduction of beta-amyloid productionBOY KENNETH M·Filed 2011·Granted Jan 28, 2014·39 cites·5 claims
- 0792US9850283B2Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Dec 26, 2017·12 cites·1 claims
- 0890US10633419B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Apr 28, 2020·7 cites·4 claims
- 0989US9809625B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Nov 7, 2017·8 cites·2 claims
- 1087US11358988B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jun 14, 2022·2 cites·8 claims
- 1187US7388007B2Gamma-lactams as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Jun 17, 2008·6 cites·8 claims
- 1286US7902218B2Substituted tetrahydroisoquinolines as β-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Mar 8, 2011·5 cites·7 claims
- 1383US11103605B2PET-imaging immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Aug 31, 2021·3 cites·11 claims
- 1482US7408071B2N-aryl pyrrolidine derivatives as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2007·Granted Aug 5, 2008·4 cites·7 claims
- 1582US6933308B2Aminoalkyl thiazole derivatives as KCNQ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Aug 23, 2005·11 cites·11 claims
- 1678US11952434B2ImmunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2022·Granted Apr 9, 2024·0 cites·6 claims
- 1776US8349880B2Bicyclic compounds for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Jan 8, 2013·4 cites·6 claims
- 1875US7002015B23-Thia-4-arylquinolin-2-one derivatives as smooth muscle relaxantsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Feb 21, 2006·6 cites·8 claims
- 1971US8637523B2Compounds for the reduction of beta-amyloid productionBOY KENNETH M·Filed 2011·Granted Jan 28, 2014·2 cites·12 claims
- 2067US2024218022A1Anti-vista macrocyclic peptides and compositionsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 2160US7145013B23-thia-4-arylquinolin-2-one derivativesBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Dec 5, 2006·1 cites·6 claims
- 2258US2013178462A1Compounds for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2013·Application pending·0 cites
- 2358US2021386876A1Pet-imaging immunomodulatorsBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2457US2017369530A1Macrocyclic inhibitors of the pd-1/pd-l1 and cd80(b7-1)/pd-l1 protein/protein interactionsBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 2556US7981913B2Isophthalates as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Granted Jul 19, 2011·0 cites·1 claims
- 2656US7745470B2Isophthalates as beta-secretase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jun 29, 2010·0 cites·2 claims
- 2756US7049309B23-Thia-4-arylquinolin-2-one potassium channel modulatorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted May 23, 2006·3 cites·8 claims
- 2851US2015336975A1Compounds for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 2950US2015152089A1Compounds for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
- 3049US7179920B23-thia-4-arylquinolin-2-one derivativesBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Feb 20, 2007·0 cites·7 claims
- 3147US7132542B2Compounds for the treatment of male erectile dysfunctionBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 7, 2006·0 cites·7 claims
- 3244US7273866B22-aryl thiazole derivatives as KCNQ modulatorsBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Sep 25, 2007·0 cites·10 claims
- 3340US9833454B2Difluoromethoxy compound with low bioactivation potential for the reduction of beta-amyloid productionBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Dec 5, 2017·0 cites·7 claims
- 3439US8710061B2Compounds for the reduction of β-amyloid productionBOY KENNETH M·Filed 2012·Granted Apr 29, 2014·0 cites·18 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →